产品编号:M425015
产品规格:50mg
产品价格:面议
| 标准品编号: | M425015 |
| 名称: | MK-0822 |
| 别名: | N-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)biphenyl-4-yl]ethyl}-L-leucinamide, Odanacatib |
| CAS号: | 603139-19-1 |
| 分子式: | C₂₅H₂₇F₄N₃O₃S |
| 外观: | 白色至白色固体 |
| 熔点: | >170°C (dec.) |
| 分子量: | 525.56 |
| 储存: | Hygroscopic, -20°C Freezer, Under inert atmosphere |
| 溶解度: | Chloroform (Slightly, Heated, Sonicated), Methanol (Slightly, Sonicated) |
| 种类: | Research Tools; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | MK-0822 is a newly developed bone-targeting dual action pro-drug for osteoporosis and bone metastasis. It is also an inhibitor of cathepsin K, an enzyme involved in bone resorption. |
| 参考文献 | |